Ovarian Epithelial Cancer
Showing 1 - 25 of >10,000
Ovarian Epithelial Cancer Trial (99mTC nanocolloid albumin injection, ICG injection)
Not yet recruiting
- Ovarian Epithelial Cancer
- 99mTC nanocolloid albumin injection
- ICG injection
- (no location specified)
Jul 6, 2023
Epithelial Ovarian Cancer: A Retrospective Study
Recruiting
- Epithelial Ovarian Cancer
- Hematologic features
-
Shanghai, Shanghai, ChinaRenji Hospital Affiliated to Shanghai Jiao Tong University Schoo
Oct 16, 2023
Early Screening of Epithelial Ovarian Cancer
Not yet recruiting
- Ovarian Cancer
- +2 more
- Fragmentomics
- (no location specified)
Jun 26, 2023
HER2-positive Breast Cancer, Stage III Ovarian Epithelial Cancer, Stage III Ovarian Germ Cell Tumor Trial in Seattle
Active, not recruiting
- HER2-positive Breast Cancer
- +8 more
- pNGVL3-hICD vaccine
- +6 more
-
Seattle, WashingtonFred Hutchinson Cancer Research Center/University of Washington
Nov 1, 2022
The Immune Landscape of Epithelial Ovarian Cancer
Recruiting
- Epithelial Ovarian Cancer
- Collection of tumor samples, blood and vaginal and rectal swabs
-
Bellinzona, SwitzerlandOncology Institute of Southern Switzerland
Aug 2, 2023
A Prospective, Randomized Controlled Study of Cyclophosphamide,
Not yet recruiting
- Epithelial Ovarian Cancer
-
Shijiazhuang, Hebei, ChinaHebei
Aug 20, 2023
Carcinoma, Ovarian Tumor, Endocrine Gland Tumor Trial in Havana (Ocoxin-Viusid)
Completed
- Carcinoma
- +12 more
- Ocoxin-Viusid
-
Havana, CubaNational Institute of Oncology and Radiobiology (INOR)
Jul 5, 2022
Ovarian Cancer Trial in New York (90Y-hu3S193, 111In-hu3S193)
Completed
- Ovarian Cancer
- 90Y-hu3S193
- 111In-hu3S193
-
New York, New YorkMemorial Sloan-Kettering Cancer Center
Oct 3, 2022
Safety of Niraparib in Korean Primary and Recurrent Epithelial
Completed
- Epithelial Ovarian Cancer
-
Seoul, Korea, Republic ofDepartment of Obstetrics and Gynecology, University of Ulsan Col
Oct 11, 2023
Epithelial Ovarian Cancer Trial (ROMA score evaluation)
Not yet recruiting
- Epithelial Ovarian Cancer
- ROMA score evaluation
- (no location specified)
Aug 7, 2023
Advanced Epithelial Ovarian Cancer Trial in Cairo (Carboplatin/paclitaxel)
Completed
- Advanced Epithelial Ovarian Cancer
-
Cairo, EgyptPharmacology and toxicology department, Faculty of Pharmacy, Cai
Jul 19, 2023
ctDNA Methylation for Epithelial Ovarian Cancer
Recruiting
- Epithelial Ovarian Cancer
- +7 more
- CDO1 and HOXA9 methylation assay
-
Beijing, Beijing, ChinaLei Li
Mar 24, 2023
Brenner Tumor, Malignant Ascites, Malignant Pleural Effusion Trial in United States (metformin HCl, , Chemotherapy)
Suspended
- Brenner Tumor
- +27 more
- metformin hydrochloride
- +2 more
-
Birmingham, Alabama
- +9 more
May 16, 2022
68Ga-FAPI PET Imaging in Detection of Ovarian Cancer Recurrence
Not yet recruiting
- 68Ga-FAPI
- +3 more
- 68Ga-FAPI
-
Shanghai, Shanghai, ChinaRen Ji Hospital, School of Medicine, Shanghai Jiao Tong Universi
May 3, 2023
High Grade Serous Ovarian Cancer (HGSOC) Trial (FAPI PET CT)
Not yet recruiting
- High Grade Serous Ovarian Cancer (HGSOC)
- FAPI PET CT
- (no location specified)
Jul 20, 2023
Ovarian Cancer Trial in France (tests to determine HRD status)
Not yet recruiting
- Ovarian Cancer
- tests to determine HRD status
-
Amiens, France
- +3 more
Nov 22, 2023
Ovarian Carcinoma Trial in New Haven (Sacituzumab govitecan)
Not yet recruiting
- Ovarian Carcinoma
- Sacituzumab govitecan
-
New Haven, ConnecticutSmilow Cancer Hospital at Yale New Haven
Aug 31, 2023
Ovarian Cancer Trial in Seoul (Cellgram-DC)
Terminated
- Ovarian Cancer
- Cellgram-DC
-
Seoul, Korea, Republic ofAsan medical center
Dec 29, 2022
Shanghai Ovarian Cancer and Family Care Project
Recruiting
- Ovarian Cancer
-
Shanghai, Shanghai, ChinaShanghai first maternity and infant hospital
Oct 31, 2023
Male Breast Cancer, Recurrent Melanoma, Stage IV Breast Cancer Trial in Columbus (propranolol HCl, Correlative Studies)
Completed
- Male Breast Cancer
- +7 more
- propranolol hydrochloride
- Correlative Studies
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Dec 4, 2022
ctDNA Methylation for Detecting Ovarian Cancer
Recruiting
- Epithelial Ovarian Cancer
- +8 more
- Methylation assay
-
Beijing, Beijing, ChinaLei Li
Mar 24, 2023
Predict Efficacy of Anti-angiogenic Therapy in Ovarian Cancer
Active, not recruiting
- Epithelial Ovarian Cancer
- liquid biopsy
-
Aviano, ItalyCentro di Riferimento Oncologico (CRO), IRCCS
May 16, 2023
Fallopian Tube Cancer, Peritoneal Cavity Cancer, Recurrent Ovarian Epithelial Cancer Trial in Duarte, Pasadena
Active, not recruiting
- Fallopian Tube Cancer
- +2 more
-
Duarte, California
- +1 more
Mar 17, 2022
Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer Trial (Luveltamab tazevibulin, Pegfilgrastim)
Not yet recruiting
- Ovarian Cancer
- +4 more
- Luveltamab tazevibulin
- Pegfilgrastim
- (no location specified)
May 12, 2023